GALRs, receptors for the neuropeptide galanin, have emerged as potential therapeutic targets for inflammatory bowel disease. Here the authors report that GAL53, a long galanin peptide derived from non ...
Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback